Oriana E. Hawkins

Identification of breast cancer peptide epitopes presented by HLA-A*0201.

Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.

Differential MHC class I expression in distinct leukocyte subsets.

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.

RAF265 inhibits the growth of advanced human melanoma tumors.

INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence.

Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia.

Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response.

Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.